Get started
Author

Annabel Kitowski

Observed name: Kitowski, Annabel
ORCID: 0000-0002-8001-5928
Observed ORCID: 0000-0002-8001-5928
OpenAlex ID: A5073834411
Vinyl Ether/Tetrazine Pair for the Traceless Release of Alcohols in Cells
2016 · Ester Jiménez‐Moreno, Zijian Guo, et al. · Angewandte Chemie International Edition · 133
PDF
Oxidative Activation of C–S Bonds with an Electropositive Nitrogen Promoter Enables Orthogonal Glycosylation of Alkyl over Phenyl Thioglycosides
2017 · Annabel Kitowski, Ester Jiménez-Moreno, et al. · Organic Letters · 28
PDF
Cyclic Dichalcogenides Extend the Reach of Bioreductive Prodrugs to Harness Thiol/Disulfide Oxidoreductases: Applications to seco -Duocarmycins Targeting the Thioredoxin System
2023 · Jan G. Felber, Annabel Kitowski, et al. · ACS Central Science · 26
PDF
Fluorogenic Chemical Probes for Wash-free Imaging of Cell Membrane Damage in Ferroptosis, Necrosis, and Axon Injury
2024 · Philipp Mauker, Daniela Beckmann, et al. · Journal of the American Chemical Society · 24
PDF
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
2019 · Malte Hellwig, Marlen C. Lauffer, et al. · Acta Neuropathologica · 24
Vinyl Ether/Tetrazine Pair for the Traceless Release of Alcohols in Cells
2016 · Ester Jiménez‐Moreno, Zijian Guo, et al. · Angewandte Chemie · 23
PDF
Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates
2022 · Filippo Carboni, Annabel Kitowski, et al. · Chemical Science · 20
PDF
A Sweet Galactose Transfer: Metabolic Oligosaccharide Engineering as a Tool To Study Glycans in Plasmodium Infection
2020 · Annabel Kitowski, Gonçalo J. L. Bernardes · ChemBioChem · 11
PDF
Expanding the payload scope in antibody-drug conjugates by delivery of hydroxy-containing drugs through self-immolative phosphoramidates
2026 · Philipp Ochtrop, Anil P. Jagtap, et al. · Nature Communications · 9
PDF
A modular scaffold for cellularly-retained fluorogenic probes for sensitive cell-resolved bioactivity imaging
2025 · Philipp Mauker, Lucas Dessen-Weissenhorn, et al. · Chemical Science · 8
PDF
TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al. · Molecular Cancer Therapeutics · 7
PDF
Abstract 2622: TUB-040, a novel Napi2b-targeting ADC built with ethynylphosphonamidate conjugation chemistry, demonstrates high and long-lasting anti-tumor efficacy via Topoisomerase-I inhibition and excellent tolerability predictive of a wide therapeutic window in humans
2024 · Saskia Schmitt, Isabelle Mai, et al. · Cancer Research · 7
Precise protein conjugation technology for the construction of homogenous glycovaccines
2020 · Annabel Kitowski, Francisco Corzana, et al. · Drug Discovery Today Technologies · 6
Abstract 2623: Enabling 5T4 for targeted cancer therapy: TUB-030, a novel ADC built with ethynylphosphonamidate conjugation chemistry, shows long-lasting anti-tumor activity via Topoisomerase-I inhibition with an optimized therapeutic index
2024 · Saskia Schmitt, Isabelle Mai, et al. · Cancer Research · 3
A Sweet Galactose Transfer – Metabolic Oligosaccharide Engineering as a Tool to Study Glycans in Plasmodium Infection
2019 · Annabel Kitowski, Gonçalo Bernardes · ChemRxiv · 2
PDF
Delivery of nano‐formulated drugs to solid tumours is selectively increased by co‐application of the vascular disrupting agent CA4P
2026 · Annabel Kitowski, Constanze Heise, et al. · British Journal of Pharmacology
Supplementary Table 1 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Table 2 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Figure 10 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Figure 5 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Figure 4 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Figure 6 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Figure 3 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Figure 7 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Supplementary Methods 1 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
2025 · Annette M. Vogl, Saskia Schmitt, et al.
Works count: 33
Citation count: 331
H-index: 9
I10-index: 8
Year
Topic
Type